Abstracts
Showing 800 abstracts.
Phase I/II randomized trial of the safety and immunogenicity of cold adapted influenza vaccine (CAIV) vs. inactivated influenza vaccine (IAIV) in HIV infected (HIV+) children; PACTG 1057.
Conference
13th Conference on Retroviruses and Opportunistic Infections
Study
P1057
Authors
Sharon Appelbaum Nachman, Myron Levin, Lin-Ye Song, Adriana Weinberg, Robert WalkerPharmacokinetics (PK) and safety of tenofovir disoproxil fumarate (TDF) in HIV-1 infected pregnant women and their infants.
Conference
13th Conference on Retroviruses and Opportunistic Infections
Authors
John H. Rodman, Patricia M. Flynn, David E. Shapiro, Arlene D. Bardeguez, Sharon Huang, Susan A. Fiscus, Koen Van Rompay, James F. Rooney, Lynne M. Mofenson, Patrick Jean-PhilippeChanges in cholesterol (CH) and triglyceride (TG) levels among pediatric patients treated with atazanavir (ATV), with/without ritonavir boosting (RTV), the 1020A NIH PACTG protocol.
Conference
13th Conference on Retroviruses and Opportunistic Infections
Study
P1020A
Authors
Pearl Samson, Richard M. Rutstein, Terence Fenton, Jennifer J. Kiser, Courtney V. Fletcher, Steven M. Schnittman, Lynne M. Mofenson, Elizabeth (Betsy) Smith, Bobbie L. Graham, Grace M. AldrovandiPopulation pharmacokinetic (PK) assessment of systemic steady-state tipranavir (TPV) concentrations for HIV+ pediatric patients administered tipranavir/ritonavir (TPV/r) 290/115 mg/m^2 and 375/150 mg/m^2 BID (BI 1182.14 and PACTG 1051 study team).
Conference
13th Conference on Retroviruses and Opportunistic Infections
Study
P1051
Authors
John Sabo, Pedro E. Cahn, Marinella Della Negra, Guido Castelli-Gattinara, Claudia Fortuny, Ram Yogev, Juan Carlos Salazar, Chan-Loi Yong, Jaromir Mikl, Ante JelaskaAnalysis of HIV-1 drug resistance and immune outcomes in HIV-1 infected youth failing initial HAART.
Conference
13th Conference on Retroviruses and Opportunistic Infections
Authors
Allison George Agwu, Kimberly Ferguson, Jane C. Lindsey, Steven D. Douglas, Bret J. Rudy, Stephen A. Spector, Patricia M. Flynn, Deborah PersaudRepeated supervised treatment interruptions (STI) with progressive increases in "off treatment" duration results in enhanced virologic control in a subset of pediatric individuals.
Conference
13th Conference on Retroviruses and Opportunistic Infections
Study
P1015
Authors
William Borkowsky, Ram Yogev, Petronella Muresan, Elizabeth (Betsy) J. McFarland, Lisa M. Frenkel, Terence Fenton, John ( Jack ) Moye, Edmund Capparelli, Nina Ellis, Barbara E. HeckmanNevirapine (NVP) pharmacokinetics (PK) with an extended prophylactic regimen during the first two weeks of life.
Conference
13th Conference on Retroviruses and Opportunistic Infections
Study
P1043/HPTN 040
Authors
Mark Mirochnick, Karin Alvarenga-Hyldgaard Nielsen, Jose Henrique Pilotto, Jorge Pinto, Eleanor Jimenez, Valdilea V. Santos, Teresa Parsons, Heather D. Watts, John ( Jack ) Moye, Yvonne J. BrysonDidanosine lowers mitchondrial DNA levels in peripheral blood mononuclear cells in HIV-1 infected children receiving HAART.
Conference
13th Conference on Retroviruses and Opportunistic Infections
Authors
Akihiko Saitoh, Terence Fenton, Carmelita Alvero, Courtney V. Fletcher, Stephen A. SpectorAdherence to antiretroviral therapy (ART) in women during and after pregnancy.
Conference
13th Conference on Retroviruses and Opportunistic Infections
Study
P1025
Authors
Arlene D. Bardeguez, Jane C. Lindsey, Susan Ellen Cohn, Jennifer S. Read, Elizabeth (Betsy) Smith, Ruth E. TuomalaSub-cutaneous interleukin-2 can achieve substantial gains in CD4 counts in HIV-infected pediatric patients who fail to achieve immune reconstitution following HAART.
Conference
13th Conference on Retroviruses and Opportunistic Infections